About 0.5 Mg Dactinomycin Injection USP
Discover the splendid efficacy of 0.5 Mg Dactinomycin Injection USP, a top-tier anti-cancer agent trusted by redoubtable hospitals and oncology centers worldwide. Each sterile glass vial, standardized at 0.5 mg, ensures preservative-free, single-dose administration via intravenous route. Shop Now to secure a product in demand, offered with competitive pricing for distributors, exporters, suppliers, and traders across India. FDA and Indian FDA approved, this orange crystalline powder (reconstituted to clear solution) is ideal for treating Wilms tumor, rhabdomyosarcoma, Ewing's sarcoma, and metastatic testicular cancer. Prescription required for hospital use only.
Therapeutic Applications and Uses
0.5 Mg Dactinomycin Injection USP is used as an advanced anti-cancer therapy. Its redoubtable action is specifically indicated for Wilms tumor, rhabdomyosarcoma, Ewing's sarcoma, and metastatic testicular cancer. The injection is dispensed for hospital and oncology center use, making it a valuable asset for healthcare providers treating patients with difficult malignancies. Commercially, it is supplied throughout India to specialists and facilities aiming to deliver top-tier chemotherapeutic care.
Premium Delivery, Valuation, and Packaging Standards
Experience premium delivery with secure orange crystalline powder vials carefully packed in cartons, ensuring product integrity in transit. Valuation for each consignment is competitive and tailored for large-scale hospital and clinical orders. Payment terms are flexible, and sample vials are available upon request for evaluation. With proper packaging and adherence to strict storage instructions (2C to 8C, protected from light), distributors can rely on prompt, efficient supply and robust shelf life of 24 months.
FAQ's of 0.5 Mg Dactinomycin Injection USP:
Q: How should the 0.5 Mg Dactinomycin Injection USP be reconstituted for use?
A: Reconstitute the vial by adding 1.1 mL of sterile water for injection, resulting in a clear solution suitable for intravenous administration.
Q: What types of cancers is this injection indicated for?
A: This injection is specifically used in the treatment protocols for Wilms tumor, rhabdomyosarcoma, Ewing's sarcoma, and metastatic testicular cancer.
Q: When is Dactinomycin Injection USP contraindicated?
A: The injection is contraindicated in patients with hypersensitivity to dactinomycin or any ingredient in the formulation. It should only be administered in hospital or oncology settings.
Q: Where should the vials be stored to maintain efficacy?
A: Store the glass vials between 2C to 8C in a location protected from light to preserve product stability and potency for up to 24 months.
Q: What is the benefit of using single-dose, preservative-free vials?
A: Single-dose, preservative-free vials reduce the risk of contamination and ensure accurate dosing, aligning with sterile hospital protocols for cytotoxic agents.
Q: How can commercial buyers acquire samples before full order placement?
A: Samples are available upon request from the distributor or supplier, allowing for product evaluation before committing to bulk purchasing.